Non-surgical Periodontal Therapy Effects Metabolic Control in Diabetics
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether nonsurgical periodontal therapy is effective in the metabolic control of patients with type II Diabetes mellitus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
Type 2 diabetes mellitus (DM2), the most common type of diabetes, is characterized by hyperglycemia, hyperlipidemia, and associated complications. The classic major complications of diabetes are microangiopathy, nephropathy, neuropathy, macrovascular disease, delayed wound healing, and periodontitis. There is an interacting, complex relationship between diabetes and periodontitis.Many studies have shown a greater incidence and a greater severity of periodontitis in diabetic patients.Meanwhile, a number of studies have suggested that periodontitis may actually be a risk factor for diabetic complications as well. This study is performed to investigate the effects of non-surgical periodontal therapy on metabolic control in DM2 patients.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Scalig and Rootplaning patients will receive scaling and root planing therapy |
Procedure: Scaling and Rootplaning
All patients in the test group receive scaling and rootplaning under local anesthesia
Other Names:
|
No Intervention: control patients in control group will not receive periodontal treatment in the time period of the study |
Outcome Measures
Primary Outcome Measures
- Metabolic control [3 months after treatment]
fasting plasma glucose (FPG), HbA1c, TG, TC, high density lipoprotein cholesterol (HDL), and LDL are measured at baseline and 3 months after treatment.
Secondary Outcome Measures
- periodontal improvement after scaling and rootplaning [3 months after treatment]
Periodontal parameters (Plaque index, Gingival index, Clinical Attachment level and Probing depth)are Measured at baseline and 3 months after treatment
Eligibility Criteria
Criteria
Inclusion Criteria:
(1) mild to moderate periodontitis according to the criteria of the American Academy of Periodontology (32); (2) diagnosis of DM2 with glycated hemoglobin (HbA1c) values over 7%; (3) no major diabetic complications; (4) blood sugar controlled with glybenclamide and metformin, without insulin administration; and (5) no systemic antibiotic administration or periodontal treatment within the last 6 months.
Exclusion Criteria:
(1) presence of systemic diseases other than DM2 that may influence the course of periodontal disease; (2) intake of immunosuppressive drugs, steroids, hydantoin, or non-steroidal anti-inflammatory drugs; (3) tobacco use; (4) pregnancy or intention to become pregnant during the study period; (5) fixed orthodontic appliances; and (5) refusal or inability to give informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mashhad Dental School, Mashhad University of Medical Sciences | Mashhad | Khorasan Razavi | Iran, Islamic Republic of | 91735-984 |
Sponsors and Collaborators
- Mashhad University of Medical Sciences
Investigators
- Study Chair: Amir Moeintaghavi, DDS.,Ms., Associate professor,Mashhad Dental School, Mashhad University of Medical Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 86067